{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:06:37Z","timestamp":1791216397113,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088360","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T17:06:49Z","timestamp":1392311209000},"page":"e88360","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy"],"prefix":"10.1371","volume":"9","author":[{"given":"Paul M. L.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Schill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha V.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Rafael-Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1093\/hmg\/ddr105","article-title":"Therapeutic approaches to muscular dystrophy","volume":"20","author":"A Goyenvalle","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mus.23272","article-title":"Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up","volume":"45","author":"L Merlini","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne\u2019s muscular dystrophy","volume":"320","author":"JR Mendell","year":"1989","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"K Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.41.12.1874","article-title":"Long-term benefit from prednisone therapy in Duchenne muscular dystrophy","volume":"41","author":"GM Fenichel","year":"1991","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/1756-0500-5-435","article-title":"Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy","volume":"5","author":"DL Machado","year":"2012","journal-title":"BMC Res Notes"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mus.880060204","article-title":"Clinical investigation in Duchenne dystrophy: 2. Determination of the \u201cpower\u201d of therapeutic trials based on the natural history","volume":"6","author":"MH Brooke","year":"1983","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Henricson E, Abresch R, Han JJ, Nicorici A, Goude Keller E, <etal>et al<\/etal>.. (2013) The 6-minute walk test and person-reported outcomes in boys with duchenne muscular dystrophy and typically developing controls: longitudinal comparisons and clinically-meaningful changes over one year. PLoS Curr 5.","DOI":"10.1371\/currents.md.9e17658b007eb79fcd6f723089f79e06"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.nmd.2010.06.014","article-title":"North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy","volume":"20","author":"E Mazzone","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.21544","article-title":"The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy","volume":"41","author":"CM McDonald","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00019052-200310000-00003","article-title":"Cardiomyopathy in muscular dystrophies","volume":"16","author":"F Muntoni","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.57.6.1122","article-title":"An ultrastructural basis for electrocardiographic alterations associated with Duchenne\u2019s progressive muscular dystrophy","volume":"57","author":"SK Sanyal","year":"1978","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.amjcard.2009.12.070","article-title":"Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy","volume":"105","author":"SC Hagenbuch","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/eurjhf\/hfp028","article-title":"Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy","volume":"11","author":"R Bauer","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice","volume":"124","author":"JA Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2007.08.029","article-title":"Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice","volume":"264","author":"L Zhou","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"G Bulfield","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"P Sicinski","year":"1989","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphys.2012.00422","article-title":"The force-temperature relationship in healthy and dystrophic mouse diaphragm; implications for translational study design","volume":"3","author":"JD Murray","year":"2012","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-5-45","article-title":"A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy","volume":"5","author":"LR Rodino-Klapac","year":"2007","journal-title":"J Transl Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"C476","DOI":"10.1152\/ajpcell.00456.2008","article-title":"Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild type mice","volume":"296","author":"PT Martin","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2119\/molmed.2010.00263","article-title":"Peptide-Based Inhibition of NF-kappaB Rescues Diaphragm Muscle Contractile Dysfunction in a Murine Model of Duchenne Muscular Dystrophy","volume":"17","author":"JM Peterson","year":"2011","journal-title":"Mol Med"},{"key":"ref23","first-page":"40","article-title":"Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview","volume":"31","author":"A De Luca","year":"2012","journal-title":"Acta Myol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e11220","DOI":"10.1371\/journal.pone.0011220","article-title":"Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy","volume":"5","author":"AD Guerron","year":"2010","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e34204","DOI":"10.1371\/journal.pone.0034204","article-title":"Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse","volume":"7","author":"A Sali","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","article-title":"Corticosteroids and the risk of atrial fibrillation","volume":"166","author":"CS van der Hooft","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/hrt.2003.025783","article-title":"Cardiac effects of anabolic steroids","volume":"90","author":"JR Payne","year":"2004","journal-title":"Heart"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1161\/01.CIR.0000147274.83071.68","article-title":"Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?","volume":"110","author":"JJ McMurray","year":"2004","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e20856","DOI":"10.1371\/journal.pone.0020856","article-title":"Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice","volume":"6","author":"LT Bish","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1074248410381757","article-title":"Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice","volume":"16","author":"CF Spurney","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00448.2005","article-title":"Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice","volume":"289","author":"PML Janssen","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Beastrom N, Lu H, Macke A, Canan BD, Johnson EK, <etal>et al<\/etal>.. (2011) mdx(5cv) Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice. Am J Pathol.","DOI":"10.1016\/j.ajpath.2011.07.009"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"42ra54","DOI":"10.1126\/scitranslmed.3000692","article-title":"A Human-Specific Deletion in Mouse Cmah Increases Disease Severity in the mdx Model of Duchenne Muscular Dystrophy","volume":"2","author":"K Chandrasekharan","year":"2010","journal-title":"Sci Transl Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:05:39Z","timestamp":1588986339000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088360"}},"subtitle":[],"editor":[{"given":"Maurilio","family":"Sampaolesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088360","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}